All stock lists
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
2.23-0.07 (-3.26%)
Insider Score
––Not scored
ELDN Insider Score
Insiders here have filed 4 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
ELDN analyst forecast
Best analysts covering ELDN
No firm covering ELDN has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ELDN analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Guggenheim | Buy | — | — | Reiterated | 2025-11-18 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-09-02 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-20 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-06-04 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-05-10 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-05-07 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-03-22 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-11-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-10-24 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2023-08-22 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-05-26 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2022-06-01 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2021-11-24 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2021-04-27 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2021-03-23 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2021-02-08 |
ELDN earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-19 | -0.20 | -0.10 | $0 | $0 |
| 2026-05-13 | -0.22 | -0.33 | $0 | $0 |
| 2026-08-13 | -0.16 | -0.27 | $0 | $0 |
| 2026-11-13 | -0.20 | 0.00 | $0 | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.